Oncology Institute Of Southern Switzerland

This study looked for biological markers that could predict early on whether the drug ibrutinib would stop working in people with a high-risk form of chronic lymphocytic leukemia (CLL) that has a TP53 mutation. Researchers followed 56 adults with CLL who were starting ibrutinib t…

This study looked at whether special heart scans (CMR) can spot early signs of heart damage in 150 breast cancer patients treated with chemotherapy and radiation. The goal was to predict cardiotoxicity, defined as a significant drop in heart function within a year after treatment…